Transforming growth factor-β1 in chronic hepatitis C

135Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Transforming growth factor-β1 (TGF-β1) has been implicated in mediating hepatic fibrogenesis and is known to have negative regulatory effects on the immune system. To analyse the effects of TGF-β1 in chronic HCV, serum samples were prospectively collected from 88 chronic hepatitis C virus (HCV) patients and 34 healthy controls. Total and biologically active TGF-β1, interleukin (IL)-4 and IL-10 were measured by enzyme-linked immunosorbent assay (ELISA). HCV RNA levels were quantified by branched DNA signal amplification pathway (bDNA), and HCV genotypes were determined by restriction fragment length polymorphism (RFLP) based on the 5′-untranslated region (UTR). Histological diagnosis was available in 87 patients, and liver sections from 80 other HCV patients were evaluated for hepatic expression of TGF-β1 using immunohistochemistry. Patients with chronic HCV infection had a higher level of TGF-β1, both total (817 ± 464 ng ml-1) and biologically active forms (520 ± 370 pg ml-1), compared with controls (total TGF-β1 183 ± 105 ng ml-1, P<0.001; active TGF-β1 290 ± 140 pg ml-1, P<0.01). There was no correlation between either total or biologically active TGF-β1 and clinical variables (age, gender, duration), liver biochemistry (serum alanine aminotransferase) or virological (HCV RNA level, genotype) parameters but there was a correlation between total TGF-β1 and Knodell scores (P = 0.03, n = 54). However, when individual histological parameters were analysed, only the fibrosis score showed significant correlation (P = 0.04, n =54). Immunohistochemistry revealed that 62% of HCV patients had TGF-β1 present in sinusoidal cells. No correlation existed between hepatic expression of TGF-β1 and any histological parameters. A trend existed towards a correlation between total TGF-β1 and IL-4 (P = 0.059, n = 74) but not with IL-10. Therefore, the TGF-β1 system is activated in chronic HCV infection and may contribute towards hepatic fibrogenesis; in addition, the TGF-β1 system may interact with IL-4. © 1997 Blackwell Science Ltd.

Author supplied keywords

References Powered by Scopus

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

3545Citations
N/AReaders
Get full text

Transforming growth factor β in tissue fibrosis

3086Citations
N/AReaders
Get full text

Classification of chronic hepatitis: Diagnosis, grading and staging

2576Citations
N/AReaders
Get full text

Cited by Powered by Scopus

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

1178Citations
N/AReaders
Get full text

NADPH oxidases: An overview from structure to innate immunity-associated pathologies

730Citations
N/AReaders
Get full text

Evaluation of liver fibrosis: A concise review

518Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nelson, D. R., Gonzalez-Peralta, R. P., Qian, K., Xu, Y., Marousis, C. G., Davis, G. L., & Lau, J. Y. N. (1997). Transforming growth factor-β1 in chronic hepatitis C. Journal of Viral Hepatitis, 4(1), 29–35. https://doi.org/10.1046/j.1365-2893.1997.00124.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

45%

Researcher 4

36%

Professor / Associate Prof. 2

18%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

50%

Biochemistry, Genetics and Molecular Bi... 4

25%

Agricultural and Biological Sciences 2

13%

Immunology and Microbiology 2

13%

Save time finding and organizing research with Mendeley

Sign up for free